The University of Chicago Header Logo

Connection

Hedy Kindler to Topoisomerase I Inhibitors

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Topoisomerase I Inhibitors.
Hedy Kindler
Connection Strength
0.040
Topoisomerase I Inhibitors
  1. Phase II trial of topotecan administered as a 21-day continuous infusion in previously untreated patients with stage IIIB and IV non-small-cell lung cancer. Am J Clin Oncol. 1998 Oct; 21(5):438-41.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.